Equity Details
Price & Market Data
Price: $0.643
Daily Change: -$0.0331 / 5.14%
Daily Range: $0.633 - $0.676
Market Cap: $6,501,199
Daily Volume: 90,576
Performance Metrics
1 Week: -5.45%
1 Month: -75.55%
3 Months: -90.17%
6 Months: -91.60%
1 Year: -93.68%
YTD: -65.62%
About BiomX Inc. (PHGE)
Keep track of BiomX Inc. (PHGE)'s market journey. Priced at 0.643, the stock reflects a daily movement of -$0.0331 / 5.14%. With a market cap of 6,501,199, explore its full spectrum of performance from YTD to 1-year.
Company Details
Employees: 20
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.